Liangshu Feng, [email protected] These authors have contributed equally to this work and share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Martin Brown has a research grant from Sanofi-Synthelabo, the company that owns tirapazamine
Heres what you need to know about BPC-157 and how it could affect your health
Les donnes prcliniques documentent des effets sur les tendons (Achille, MCL, rotulien), les muscles, la peau (cicatrisation cutane), les os, les nerfs priphriques, le tractus gastro-intestinal (ulcres, colites) et le tissu cardiaque
Studies investigating BPC-157 brain injury models, such as traumatic brain injury (TBI) in rats, have found that its administration can reduce neuronal damage, mitigate cerebral edema, and improve functional outcomes
How many Vitamin D injections will I need